Locally advanced inoperable primary or recurrent non-small cell lung cancer treated with 4-week hypofractionated radiation therapy (3  Gy/fraction)

ConclusionIn patients not suitable of concurrent radio-chemotherapy, exclusive or sequential hypofractionated schedule using 60  Gy in 20 fractions was well tolerated and presented promising results. Complete local response was a predictor of better outcomes, and any efforts will be made to perform prospective clinical trials to further evaluate hypofractionated regimens with increased lesional BED.
Source: La Radiologia Medica - Category: Radiology Source Type: research